Evidence map›Paper›PMID 27334517›Full record

ArticleClinical and experimental otorhinolaryngology2017

Preoperative Lymph Node Staging by FDG PET/CT With Contrast Enhancement for Thyroid Cancer: A Multicenter Study and Comparison With Neck CT.

Ari Chong, Jung-Min Ha, Yeon-Hee Han, Eunjung Kong, Yunjung Choi, Ki Hwan Hong, Jun-Hee Park, Sung Hoon Kim, Jung Mi Park

Abstract read
In one paragraph

Article in Clinical and experimental otorhinolaryngology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. KSNM60 in Nuclear Endocrinology: from the Beginning to the Future.Nuclear medicine and molecular imaging · 2022
    Review
  4. Review
  5. The Use ofMolecular imaging and radionuclide therapy · 2021
    Article
  6. KSNM60 in Clinical Nuclear Oncology.Nuclear medicine and molecular imaging · 2021
    Review
  7. Article
  8. Journal of cancer research and clinical oncology · 2020
    Article
  9. Article
  10. Article
  11. Efficacy ofOTO open
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ari ChongDepartment of Nuclear Medicine, Chosun University Hospital, Gwangju, Korea.
Jung-Min HaDepartment of Nuclear Medicine, Chosun University Hospital, Gwangju, Korea.
Yeon-Hee HanDepartment of Nuclear Medicine, Chonbuk National University Hospital, Jeonju, Korea.
Eunjung KongDepartment of Nuclear Medicine, Yeungnam University Medical Center, Daegu, Korea.
Yunjung ChoiDepartment of Nuclear Medicine, Hallym University Sacred Heart Hospital, Anyang, Korea.
Ki Hwan HongDepartment of Otolaryngology-Head and Neck Surgery, Research Institute of Clinical Medicine, Chonbuk National University Hospital, Chonbuk National University Medical School, Jeonju, Korea.
Jun-Hee ParkDepartment of Otolaryngology-Head and Neck Surgery, Chosun University College of Medicine, Gwangju, Korea.
Sung Hoon KimDepartment of Radiology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Jung Mi ParkDepartment of Nuclear Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe purpose of this study was to compare lymph node (LN) staging using

methodsThis was a retrospective multicenter study. A total of 85 patients were enrolled. Patients who underwent a preoperative evaluation by CE PET/CT and neck CT for thyroid cancer were enrolled. The gold standard for LN was the combination of surgical pathology and clinical follow-up. We compared CE PET/CT with neck CT using a level-by-level method. Factors, including age, sex, camera, arm position, tumor size, extra-thyroidal extension, tumor location, number of primary tumors, primary tumor maximum standardized uptake value, and the interval from scan to operation were also analyzed.

resultsOverall accuracy was 81.2% for CE PET/CT and 68.2% for neck CT. CE PET/CT was more sensitive than neck CT (65.8% vs. 44.7%). Also, CE PET/CT showed higher negative predictive value (77.2% vs. 66.1%). CE PET/CT showed good agreement with the gold standard (weighted kappa [κ], 0.7) for differentiating N0, N1a, and N1b, whereas neck CT showed moderate agreement (weighted κ, 0.5). CE PET/CT showed better agreement for the number of levels involved with the gold standard (weighted κ, 0.7) than that of neck CT with the gold standard (weighted κ, 0.5). The accuracies for differentiating N0, N1a, and N1b were 81.2% for CE PET/CT and 68.2% for neck CT. Level-by-level analysis showed that CE PET/CT was more sensitive and has higher negative predictive value for detecting ipsilateral level IV and level VI LNs than neck CT. Other analyzed factors were not related to accuracies of both modalities.

conclusionCE PET/CT was more sensitive and reliable than neck CT for preoperative LN staging in patients with thyroid cancer.

Indexed as

Computed TomographyFluorodeoxyglucose F18Positron-Emission TomographyThyroid Neoplasms

Identifiers

PMID27334517
PMCPMC5327587

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.